2BB score and signals
Taysha Gene Therapies, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 23 | Low |
| Momentum | 32 | Weakening |
| Financial strength | 25 | Weak |
| Quality | 80 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| Headquarters | Dallas, Texas, United States |
| Founded | 2019 |
| Employees | 99 |
| 52-week range | $2.72 – $7.30 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.128 | — | $630,543.00 |
| 2026-08-11 | -0.13 | -0.1189 | $0.00 | $693,600.00 |
| 2026-05-06 | -0.12 | -0.0996 | $0.00 | $693,600.00 |
| 2026-03-19 | -0.08 | -0.0981 | $5.49M | $1.93M |
Related companies
2BBBullish & Bearish